Anzeige
Mehr »
Montag, 02.03.2026 - Börsentäglich über 12.000 News
Erste Psilocybin-Behandlungen laufen - warum steht Optimi noch bei Pennystock-Level?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DNWV | ISIN: SK1000025322 | Ticker-Symbol: 91X
Frankfurt
02.03.26 | 08:05
9,320 Euro
-0,21 % -0,020
Branche
Rohstoffe
Aktienmarkt
OSTEUROPA
1-Jahres-Chart
GEVORKYAN AS Chart 1 Jahr
5-Tage-Chart
GEVORKYAN AS 5-Tage-Chart

Aktuelle News zur GEVORKYAN Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08:10GEVORKYAN, a.s.: GEVORKYAN in Nuremberg: new projects in the tens of millions of EUR72GEVORKYAN, a.s. presented itself over the past week as an exhibitor at two events in Nuremberg, Germany: Enforce Tac, a specialized trade fair for defence and security, and IWA OutdoorClassics, one...
► Artikel lesen
GEVORKYAN Aktie jetzt für 0€ handeln
MiGEVORKYAN, a.s.: 94 new customers236GEVORKYAN, a.s. announces the completion of due diligence and the signing of an agreement for the acquisition of a plant in Italy. Formal approvals by the authorities are underway and will be completed...
► Artikel lesen
17.02.GEVORKYAN, a.s.: GEVORKYAN in the Portfolio of a Goldman Sachs Fund650"According to publicly available data, the Goldman Sachs Central Europe Equity fund, managed by Goldman Sachs, holds an exposure to GEVORKYAN, a.s. within its regional investment strategy focused on...
► Artikel lesen
09.02.GEVORKYAN, a.s.: ESOP - shares for key employees280GEVORKYAN, a.s. has launched its Employee Stock Ownership Plan (ESOP) for the first time, enabling employees to acquire company shares on preferential terms. In the first round, shares were allocated...
► Artikel lesen
09.02.XFRA NEW INSTRUMENTS AVAILABLE ON 09.02.2026268The following instruments on XETRA do have their first trading 09.02.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 09.02.2026 Aktien 1 CNE100007CV2 Muyuan Foods Co. Ltd. 2...
► Artikel lesen
28.01.GEVORKYAN, a.s.: Sintered armour140GEVORKYAN, a.s. is expanding its activities in the field of defence technologies with a new development program focused on armour protection for multiple types of use. The project aims to develop solutions...
► Artikel lesen
12.01.GEVORKYAN, a.s.: Patria Finance opens new opportunities for investors256GEVORKYAN, a.s., listed on the Prague Stock Exchange, welcomes the expansion of the investment group Patria Finance into Slovakia. Slovak investors thus gain another convenient option to purchase GEVORKYAN...
► Artikel lesen
18.12.25GEVORKYAN, a.s.: Dr. Kalliwoda: Convincing Q3 2025 Results with a Bright Outlook167"GEVORKYAN delivered strong financial and operational performance for the first three quarters of 2025, showing clear year-on-year improvement compared with Q3 2024. The comparison with Q3 2024 confirms...
► Artikel lesen
17.12.25GEVORKYAN, a.s.: GEVORKYAN: Educating people is the foundation for growth149"We see educating people as a strategic investment, not an obligation. In the spirit of Tomáš Bata's ideas, I believe that the quality of a company depends on the quality of its people," says GEVORKYAN...
► Artikel lesen
08.12.25GEVORKYAN, a.s.: Contract with Czechoslovak Group and positive investor feedback at the WOOD & Co Conference312WOOD & Company EMEA Conference - interest and positive reactions to the results and vision of GEVORKYAN GEVORKYAN, a.s., listed on the Prague Stock Exchange, participated in the prestigious WOOD'S...
► Artikel lesen
01.12.25GEVORKYAN, a.s.: Technological flexibility opens up new markets for GEVORKYAN195GEVORKYAN, listed on the Prague Stock Exchange, continues its stable growth and further demonstrates strong demand for its production and technological capacities across industrial sectors. New...
► Artikel lesen
19.11.25GEVORKYAN, a.s.: Strong results, plan fulfilment. Q3 2025: EBITDA growth of over 17% YoY.300 Key events for GEVORKYAN in Q3 2025: Revenue increased by 8.7% YoY to over EUR 63.5 millionEBITDA amounted to nearly EUR 23 million, representing YoY growth of over 17% EBITDA margin increased by...
► Artikel lesen
17.11.25GEVORKYAN, a.s. to release Q3 2025 financial results on November 19, 2025196GEVORKYAN, a.s. will release its selected financial and operating results for the third quarter of 2025 on Wednesday, November 19, 2025, at 8:00 a.m. CET. The company also invites you to an online...
► Artikel lesen
11.11.25GEVORKYAN, a.s.: GEVORKYAN stock analysis: Target Price CZK 321, Growth up to +40%228"Using our DCF model and a calculated WACC of 6,9 %, we determine a fair value of CZK 300 and a 12-month price target of CZK 321," notes Dr. Kalliwoda Research GmbH in analytical report GEVORKYAN, a.s....
► Artikel lesen
04.11.25GEVORKYAN, a.s.: GEVORKYAN stock analysis: Target price +53% up to 330 CZK295"Applying standard valuation multiples to the annualized H1 2025 results, the fair value of the share is estimated to range between 310 CZK and 330 CZK, indicating that the current market price does...
► Artikel lesen
28.10.25GEVORKYAN, a.s.: GEVORKYAN Force Defense (G-FD) - a significant milestone for the development of the defense industry371GEVORKYAN Force Defense (G-FD) Building on many years of cooperation in the development and production of components for the arms industry, GEVORKYAN, a.s. has established a subsidiary, GEVORKYAN...
► Artikel lesen
17.10.25GEVORKYAN, a.s.: Raw materials for the arms industry - the beginning of vertical integration293Press Release Vlkanová, Slovakia, 17. October 2025 Raw materials for the arms industry - the beginning of vertical integration Ammunition for PolandGEVORKYAN, a.s. has successfully completed...
► Artikel lesen
17.09.25GEVORKYAN, a.s.: H1 2025 Trading Update: EBITDA Up 15% YoY. Strong Results, Better Outlook227Prague, 17 September 2025 GEVORKYAN H1 2025 Highlights: Revenues increased by 11% YoY to over EUR 42.1 million EBITDA grew by 15% YoY, reaching EUR 13.8 million EBITDA margin 1.2 p.p. up...
► Artikel lesen
20.08.25Innovations in the arms industry - the basis for growth GEVORKYAN, a.s.278PRESS RELEASE Innovations in the arms industry - the basis for growth GEVORKYAN, a.s. The company strengthens its position on world markets by diversifying its portfolio by focusing...
► Artikel lesen
26.06.25GEVORKYAN, a.s.: Share Buybacks, Acquisitions, Arms Industry: Strategic Pillars to 2027293The share buyback programme for employees was approved at the Annual General Meeting held on December 10, 2024. Following approval, several months were required to prepare for the programme's launch...
► Artikel lesen
Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1